$34.90
-1.55-4.25%
At close: -
$34.90
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Xenon Pharmaceuticals Insider Trading Activity | NASDAQ:XENE | Benzinga
Track the latest Xenon Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Xenon Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Xenon Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Xenon Pharmaceuticals Inc
Shares Outstanding
76.543M
Insider Shares Owned
542.849K
Insider Percentage Owned
0.71%
Institutional Shares Held
42.447M
Institutional Percentage Held
55.5%
| Jan 27, 2025 | IAN MORTIMER | PRESIDENT & CEO | 0.00 | $29.01 | -$1.24M | SELL-OPTIONS | 0.00% | 45.60K | Jan 23 - Jan 27 | View |
| Dec 19, 2024 | SHERRY AULIN | CHIEF FINANCIAL OFFICER | 0.00 | $26.01 | -$771.00K | SELL-OPTIONS | 0.00% | 0.00 | Dec 18 | View |
| Nov 22, 2024 | GARY PATOU | — | 0.00 | $25.50 | -$200.98K | SELL-OPTIONS | 0.00% | 28.48K | Nov 22 | View |
| Mar 11, 2024 | ELIZABETH GAROFALO | — | 0.00 | $32.22 | -$95.62K | SELL-OPTIONS | 0.00% | 0.00 | Mar 08 | View |
| Mar 08, 2024 | SHERRINGTON ROBIN | EVP, STRATEGY & INNOVATION | 0.00 | $28.04 | -$314.30K | SELL-OPTIONS | 0.00% | 8.40K | Mar 07 | View |
| Mar 08, 2024 | STEVEN GANNON | — | -13.00K | $46.28 | -$601.61K | SELL | -86.67% | 2.00K | Mar 07 | View |
| Dec 15, 2023 | GARY PATOU | — | -7.60K | $24.75 | -$741.41K | SELL | -60.78% | 4.90K | Dec 13 | View |
| Aug 24, 2023 | Dawn Svoronos | — | -25.00K | $38.70 | -$967.50K | SELL | -50.00% | 25.00K | Aug 24 | View |
| Jun 01, 2023 | SIMON PIMSTONE | — | -49.01K | $27.03 | -$5.05M | SELL | -89.09% | 6.00K | May 30 - Jun 01 | View |
| May 26, 2023 | IAN MORTIMER | PRESIDENT & CEO | 25.30K | $25.57 | -$1.16M | SELL-OPTIONS | 124.64% | 45.60K | May 24 | View |
| Mar 24, 2023 | JOHN CHRISTOPHER KENNEY | CHIEF MEDICAL OFFICER | -700.00 | $35.01 | -$24.51K | SELL | -100.00% | 0.00 | Mar 24 | View |
| Mar 09, 2023 | SIMON PIMSTONE | DIRECTOR | 49.01K | $19.82 | -$661.25K | SELL-OPTIONS | 816.77% | 55.01K | Mar 07 | View |
| Nov 28, 2022 | GARY PATOU | DIRECTOR | -2.06K | $18.61 | -$136.61K | SELL | -5.39% | 36.07K | Nov 23 - Nov 25 | View |
| Sep 07, 2022 | SHERRY AULIN | CHIEF FINANCIAL OFFICER | 0.00 | $23.27 | -$607.71K | SELL-OPTIONS | 0.00% | 0.00 | Sep 02 | View |
| Sep 02, 2022 | Cassandra Robinson Attorney-in-fact | EVP, STRATEGY & INNOVATION | -436.00 | $21.30 | -$2.49M | SELL | -2.53% | 16.80K | Aug 31 - Sep 01 | View |
| Aug 16, 2022 | JAMES EMPFIELD | EVP, DRUG DISCOVERY | 0.00 | $21.26 | -$2.21M | SELL-OPTIONS | 0.00% | 10.00K | Aug 12 | View |
| Aug 16, 2022 | SIMON PIMSTONE | DIRECTOR | -177.13K | $38.25 | -$6.78M | SELL | -96.72% | 6.00K | Aug 12 - Aug 16 | View |
| Mar 08, 2022 | SIMON PIMSTONE | DIRECTOR | -27.05K | $16.51 | -$1.59M | SELL | -12.87% | 183.13K | Mar 04 - Mar 08 | View |
| Mar 08, 2022 | Cassandra Robinson Attorney-in-fact | EVP, STRATEGY & INNOVATION | -15.00K | $17.10 | -$656.90K | SELL | -46.54% | 17.23K | Mar 04 | View |
| Mar 08, 2022 | JAMES EMPFIELD | EVP, DRUG DISCOVERY | 0.00 | $19.04 | -$1.57M | SELL-OPTIONS | 0.00% | 10.00K | Mar 04 - Mar 07 | View |
| Jan 21, 2022 | JOHN CHRISTOPHER KENNEY | CHIEF MEDICAL OFFICER | 700.00 | $28.81 | $20.17K | BUY | ∞ | 700.00 | Jan 21 | View |
| Dec 07, 2021 | Christopher Seggern Von | CHIEF COMMERCIAL OFFICER | 4.00K | $24.40 | $97.60K | BUY | ∞ | 4.00K | Dec 06 | View |
| Nov 16, 2021 | SIMON PIMSTONE | DIRECTOR | -17.56K | $31.33 | -$550.06K | SELL | -7.71% | 210.19K | Nov 15 | View |
| Jun 01, 2021 | Cassandra Robinson Attorney-in-fact | EVP, STRATEGY & INNOVATION | 15.44K | $11.33 | -$95.94K | SELL-OPTIONS | 91.90% | 32.23K | May 28 | View |
| Jun 01, 2021 | FRANK HOLLER | DIRECTOR | 21.61K | $11.26 | -$180.88K | SELL-OPTIONS | 17.54% | 144.84K | May 27 | View |
| Jun 02, 2020 | SIMON PIMSTONE | — | -8.00K | $14.15 | -$113.24K | SELL | -2.86% | 271.65K | May 29 - Jun 01 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.